Histone deacetylase inhibition attenuates hepatic steatosis in rats with experimental Cushing's syndrome

Cushing's syndrome (CS) is a collection of symptoms caused by prolonged exposure to excess cortisol. Chronically elevated glucocorticoid (GC) levels contribute to hepatic steatosis. We hypothesized that histone deacetylase inhibitors (HDACi) could attenuate hepatic steatosis through glucocortic...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Korean J Physiol Pharmacol
Huvudupphovsmän: Kim, Mina, Lee, Hae-Ahm, Cho, Hyun-Min, Kang, Seol-Hee, Lee, Eunjo, Kim, In Kyeom
Materialtyp: Artigo
Språk:Inglês
Publicerad: The Korean Physiological Society and The Korean Society of Pharmacology 2018
Ämnen:
Original Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5746509/
https://ncbi.nlm.nih.gov/pubmed/29302209
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4196/kjpp.2018.22.1.23
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk